Gianforcaro A, et al. - In this study, researchers tested the hypothesis that pre-arrest antiplatelet and anticoagulant medication use would be associated with less post-arrest organ dysfunction and better outcomes. Preventing intra-arrest and post-arrest microvascular thrombosis via antiplatelet agents after out-of-hospital cardiac arrest (OHCA) were suggested as a novel therapeutic target for improving outcomes.